Rising prevalence of chronic diseases such as diabetes and renal disorders driving the demand for blood gas and electrolyte analyzers in the healthcare industry. Technological advancements in the field of point-of-care testing leading to the development of advanced analyzers with improved accuracy and efficiency. Increasing adoption of portable and handheld analyzers for rapid on-site testing in emergency situations and critical care settings.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott Point of Care, Cornley Hi-tech, Radiometer Medical ApS, EDAN Instruments,, ERBA Diagnostics Mannheim, F Hoffman La Roche., Fortress Diagnostics, Instrumentation Laboratories, LifeHealth, Medica Corp., Nova Biomedical Corp., OPTI Medical Systems,, Sensa Core, Siemens Medical Solutions USA, |
High cost associated with the procurement and maintenance of blood gas and electrolyte analyzers limiting the adoption among small healthcare facilities and resource-constrained regions. Stringent regulatory requirements and quality control standards posing challenges for market players in terms of product development and commercialization.